Blood Warmers Market Growth & Trends
The global blood warmer market size is expected to reach USD 383.43 billion by 2030, registering a CAGR of 8.61% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidences of road accidents, mishaps and other injuries, rising burden of hypothermia cases along with growing demand for blood warmers from ambulatory services and military/defense sectors, operating in extreme temperature environments are expected to propel the market demand for such devices over the forecast period.
ver the recent past, the COVID-19 pandemic has been associated with surges in hospitalization globally, this is expected to have a positive impact on the market. The demand for infusion therapy surged significantly during this period. This is one of the key factors driving up demand for blood warmer devices, which are used to raise fluids to body temperature, speed up patient recovery, and reduce the danger of transfusion shock.
Moreover, various manufacturers are adopting strategies such as mergers and acquisitions, partnerships, and product launches to strengthen their foothold in the market. For instance, in December 2020, Danish MedTech Company MEQU released the Power Pack, a new battery for its M Warmer System, a compact blood and IV fluid-warming systems. The system is commonly used in prehospital emergency settings. Such product launches are expected to propel the market over the forecast period.
Blood Warmers Market Report Highlights
- The non-portable blood-IV fluid warmers segment held the largest market share in 2024. The growing incidence of road accidents, gunshot wounds, and mishaps is expected to drive segment growth.
- The surgery segment held the largest share of 36.69% in 2024. It is anticipated to grow fastest in the coming years.
- The hardware segment held the largest share in 2024. It is also anticipated to grow fastest at a CAGR of 8.88% in the coming years.
- The rapid/fast flow warmers segment dominated the market and is expected to grow at the fastest CAGR of 9.31% over the forecast period.
- The hospitals/ clinics segment held the largest share of 66.44% in 2024. Hospitals and clinics are the primary end users of blood warmers.
- North America blood warmer market held the largest revenue share globally of more than 45.47% in 2024.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Blood Warmer Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising incidence of cold weather injuries
- 3.2.1.2. Increasing number of surgeries and trauma cases
- 3.2.1.3. Growing demand for blood warmer from ambulance services, military & defense sector
- 3.2.1.4. Advancements in blood warmer
- 3.2.2. Market restraint analysis
- 3.2.2.1. Recalls of blood warmer devices
- 3.2.2.2. Stringent regulations associated with blood warmer devices
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Growing demand for portable blood warmer
- 3.2.3.2. Distribution agreements for blood warmer
- 3.2.3.3. Expansion opportunities in cold weather countries
- 3.2.4. Market challenge analysis
- 3.2.4.1. Complications and adverse events associated with the use of blood warmer
- 3.3. Blood Warmer Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.3. Technological landscape
- Chapter 4. Blood Warmer Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Blood Warmer Market Movement Analysis
- 4.3. Global Blood Warmer Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Portable Blood/IV Warmers
- 4.4.1. Portable blood/iv warmers market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Non-portable Blood/IV Warmers
- 4.5.1. Non-portable blood/iv warmers market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 5. Blood Warmer Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Blood Warmer Market Movement Analysis
- 5.3. Global Blood Warmer Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Surgery
- 5.4.1. Surgery market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Pediatrics
- 5.5.1. Pediatrics market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Acute Care
- 5.6.1. Acute care market estimates and forecast 2018 to 2030 (USD Million)
- 5.7. Homecare
- 5.7.1. Homecare market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 6. Blood Warmer Devices: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Blood Warmer Market Movement Analysis
- 6.3. Global Blood Warmer Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals/Clinics
- 6.4.1. Hospitals/clinics market estimates and forecast 2018 to 2030 (USD Million)
- 6.5. Ambulatory Services
- 6.5.1. Ambulatory services market estimates and forecast 2018 to 2030 (USD Million)
- 6.6. Defense Forces
- 6.6.1. Defense forces market estimates and forecast 2018 to 2030 (USD Million)
- 6.7. Rescue Forces
- 6.7.1. Rescue forces market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 7. Blood Warmer Market: Flow Rate Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Blood Warmer Market Movement Analysis
- 7.3. Global Blood Warmer Market Size & Trend Analysis, by Flow Rate, 2018 to 2030 (USD Million)
- 7.4. Rapid/Fast Flow Warmers
- 7.4.1. Rapid/fast flow warmers market estimates and forecast 2018 to 2030 (USD Million)
- 7.5. Routine/Standard Flow Warmers
- 7.5.1. Routine/standard flow warmers market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 8. Blood Warmer Market: Type Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Global Blood Warmer Market Movement Analysis
- 8.3. Global Blood Warmer Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 8.4. Hardware
- 8.4.1. Hardware market estimates and forecast 2018 to 2030 (USD Million)
- 8.5. Consumables
- 8.5.1. Consumables market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 9. Blood Warmer Market: Regional Estimates & Trend Analysis
- 9.1. Regional Dashboard
- 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 9.3. North America
- 9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.3.2. U.S.
- 9.3.2.1. Key country dynamics
- 9.3.2.2. Competitive scenario
- 9.3.2.3. Regulatory framework
- 9.3.2.4. Reimbursement scenario
- 9.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 9.3.3. Canada
- 9.3.3.1. Key country dynamics
- 9.3.3.2. Competitive scenario
- 9.3.3.3. Regulatory framework
- 9.3.3.4. Reimbursement scenario
- 9.3.3.5. Canada market estimates and forecasts, 2018 - 2030
- 9.3.4. Mexico
- 9.3.4.1. Key country dynamics
- 9.3.4.2. Competitive scenario
- 9.3.4.3. Regulatory framework
- 9.3.4.4. Reimbursement scenario
- 9.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
- 9.4. Europe
- 9.4.1. UK
- 9.4.1.1. Key country dynamics
- 9.4.1.2. Competitive scenario
- 9.4.1.3. Regulatory framework
- 9.4.1.4. Reimbursement scenario
- 9.4.1.5. UK market estimates and forecasts, 2018 - 2030
- 9.4.2. Germany
- 9.4.2.1. Key country dynamics
- 9.4.2.2. Competitive scenario
- 9.4.2.3. Regulatory framework
- 9.4.2.4. Reimbursement scenario
- 9.4.2.5. Germany market estimates and forecasts, 2018 - 2030
- 9.4.3. France
- 9.4.3.1. Key country dynamics
- 9.4.3.2. Competitive scenario
- 9.4.3.3. Regulatory framework
- 9.4.3.4. Reimbursement scenario
- 9.4.3.5. France market estimates and forecasts, 2018 - 2030
- 9.4.4. Italy
- 9.4.4.1. Key country dynamics
- 9.4.4.2. Competitive scenario
- 9.4.4.3. Regulatory framework
- 9.4.4.4. Reimbursement scenario
- 9.4.4.5. Italy market estimates and forecasts, 2018 - 2030
- 9.4.5. Spain
- 9.4.5.1. Key country dynamics
- 9.4.5.2. Competitive scenario
- 9.4.5.3. Regulatory framework
- 9.4.5.4. Reimbursement scenario
- 9.4.5.5. Spain market estimates and forecasts, 2018 - 2030
- 9.4.6. Denmark
- 9.4.6.1. Key country dynamics
- 9.4.6.2. Competitive scenario
- 9.4.6.3. Regulatory framework
- 9.4.6.4. Reimbursement scenario
- 9.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 9.4.7. Sweden
- 9.4.7.1. Key country dynamics
- 9.4.7.2. Competitive scenario
- 9.4.7.3. Regulatory framework
- 9.4.7.4. Reimbursement scenario
- 9.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 9.4.8. Norway
- 9.4.8.1. Key country dynamics
- 9.4.8.2. Competitive scenario
- 9.4.8.3. Regulatory framework
- 9.4.8.4. Reimbursement scenario
- 9.4.8.5. Norway market estimates and forecasts, 2018 - 2030
- 9.5. Asia Pacific
- 9.5.1. Japan
- 9.5.1.1. Key country dynamics
- 9.5.1.2. Competitive scenario
- 9.5.1.3. Regulatory framework
- 9.5.1.4. Reimbursement scenario
- 9.5.1.5. Japan market estimates and forecasts, 2018 - 2030
- 9.5.2. India
- 9.5.2.1. Key country dynamics
- 9.5.2.2. Competitive scenario
- 9.5.2.3. Regulatory framework
- 9.5.2.4. Reimbursement scenario
- 9.5.2.5. India market estimates and forecasts, 2018 - 2030
- 9.5.3. China
- 9.5.3.1. Key country dynamics
- 9.5.3.2. Competitive scenario
- 9.5.3.3. Regulatory framework
- 9.5.3.4. Reimbursement scenario
- 9.5.3.5. China market estimates and forecasts, 2018 - 2030
- 9.5.4. South Korea
- 9.5.4.1. Key country dynamics
- 9.5.4.2. Competitive scenario
- 9.5.4.3. Regulatory framework
- 9.5.4.4. Reimbursement scenario
- 9.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 9.5.5. Australia
- 9.5.5.1. Key country dynamics
- 9.5.5.2. Competitive scenario
- 9.5.5.3. Regulatory framework
- 9.5.5.4. Reimbursement scenario
- 9.5.5.5. Australia market estimates and forecasts, 2018 - 2030
- 9.5.6. Thailand
- 9.5.6.1. Key country dynamics
- 9.5.6.2. Competitive scenario
- 9.5.6.3. Regulatory framework
- 9.5.6.4. Reimbursement scenario
- 9.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 9.6. Latin America
- 9.6.1. Brazil
- 9.6.1.1. Key country dynamics
- 9.6.1.2. Competitive scenario
- 9.6.1.3. Regulatory framework
- 9.6.1.4. Reimbursement scenario
- 9.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 9.6.2. Argentina
- 9.6.2.1. Key country dynamics
- 9.6.2.2. Competitive scenario
- 9.6.2.3. Regulatory framework
- 9.6.2.4. Reimbursement scenario
- 9.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
- 9.7. MEA
- 9.7.1. South Africa
- 9.7.1.1. Key country dynamics
- 9.7.1.2. Competitive scenario
- 9.7.1.3. Regulatory framework
- 9.7.1.4. Reimbursement scenario
- 9.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 9.7.2. Saudi Arabia
- 9.7.2.1. Key country dynamics
- 9.7.2.2. Competitive scenario
- 9.7.2.3. Regulatory framework
- 9.7.2.4. Reimbursement scenario
- 9.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 9.7.3. UAE
- 9.7.3.1. Key country dynamics
- 9.7.3.2. Competitive scenario
- 9.7.3.3. Regulatory framework
- 9.7.3.4. Reimbursement scenario
- 9.7.3.5. UAE market estimates and forecasts, 2018 - 2030
- 9.7.4. Kuwait
- 9.7.4.1. Key country dynamics
- 9.7.4.2. Competitive scenario
- 9.7.4.3. Regulatory framework
- 9.7.4.4. Reimbursement scenario
- 9.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030
- Chapter 10. Competitive Landscape
- 10.1. Market Participant Categorization
- 10.2. Key Company Profiles
- 10.2.1. GENTHERM
- 10.2.1.1. Company overview
- 10.2.1.2. Financial performance
- 10.2.1.3. Product benchmarking
- 10.2.1.4. Strategic initiatives
- 10.2.2. Belmont Medical Technologies
- 10.2.2.1. Company overview
- 10.2.2.2. Financial performance
- 10.2.2.3. Product benchmarking
- 10.2.2.4. Strategic initiatives
- 10.2.3. 3M
- 10.2.3.1. Company overview
- 10.2.3.2. Financial performance
- 10.2.3.3. Product benchmarking
- 10.2.3.4. Strategic initiatives
- 10.2.4. ICU Medical, Inc.
- 10.2.4.1. Company overview
- 10.2.4.2. Financial performance
- 10.2.4.3. Product benchmarking
- 10.2.4.4. Strategic initiatives
- 10.2.5. TSC Life
- 10.2.5.1. Company overview
- 10.2.5.2. Financial performance
- 10.2.5.3. Product benchmarking
- 10.2.5.4. Strategic initiatives
- 10.2.6. MEQU.
- 10.2.6.1. Company overview
- 10.2.6.2. Financial performance
- 10.2.6.3. Product benchmarking
- 10.2.6.4. Strategic initiatives
- 10.2.7. Estill Medical Technologies, Inc
- 10.2.7.1. Company overview
- 10.2.7.2. Financial performance
- 10.2.7.3. Product benchmarking
- 10.2.7.4. Strategic initiatives
- 10.2.8. Quality In Flow Ltd (QinFlow)
- 10.2.8.1. Company overview
- 10.2.8.2. Financial performance
- 10.2.8.3. Product benchmarking
- 10.2.8.4. Strategic initiatives
- 10.2.9. Biegler GmbH
- 10.2.9.1. Company overview
- 10.2.9.2. Financial performance
- 10.2.9.3. Product benchmarking
- 10.2.9.4. Strategic initiatives
- 10.2.10. Labtron Equipment Ltd.
- 10.2.10.1. Company overview
- 10.2.10.2. Financial performance
- 10.2.10.3. Product benchmarking
- 10.2.10.4. Strategic initiatives
- 10.2.11. North American Rescue, LLC
- 10.2.11.1. Company overview
- 10.2.11.2. Financial performance
- 10.2.11.3. Product benchmarking
- 10.2.11.4. Strategic initiatives
- 10.3. Heat Map Analysis/ Company Market Position Analysis
- 10.4. Estimated Company Market Share Analysis, 2024
- 10.5. List of Other Key Market Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook